4-Bromo-1H,2H,3H-pyrrolo[2,3-b]pyridine
97%
- Product Code: 154481
CAS:
1393534-35-4
Molecular Weight: | 199.05 g./mol | Molecular Formula: | C₇H₇BrN₂ |
---|---|---|---|
EC Number: | MDL Number: | MFCD20258857 | |
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | -20°C, Sealed, Dry |
Product Description:
Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure allows for selective functionalization, making it valuable in creating biologically active molecules. Commonly employed in medicinal chemistry for constructing fused heterocyclic systems that exhibit antitumor and anti-inflammatory activities. Also utilized in research settings to develop new neuroprotective agents and treatments for central nervous system disorders.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
100mg | 10-20 days | €217.52 |
+
-
|
250mg | 10-20 days | €402.95 |
+
-
|
1g | 10-20 days | €1,100.74 |
+
-
|
4-Bromo-1H,2H,3H-pyrrolo[2,3-b]pyridine
Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure allows for selective functionalization, making it valuable in creating biologically active molecules. Commonly employed in medicinal chemistry for constructing fused heterocyclic systems that exhibit antitumor and anti-inflammatory activities. Also utilized in research settings to develop new neuroprotective agents and treatments for central nervous system disorders.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
€0.00
€0.00
Total :